Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $7.00 target price on the stock. Several other brokerages also recently commented on ANIX. D. Boral Capital reiterated a “buy” rating and set a $10.00 price target […]
More Stories
Val Kilmer, Iconic Actor Known for ‘Top Gun’ and ‘Batman Forever,’ Dies at 65
Val Kilmer, the versatile actor celebrated for his roles in “Top Gun,” “Batman Forever,” and “The Doors,” passed away on...
Vanguard Group Inc. Acquires 356,317 Shares of Bloom Energy Co. (NYSE:BE)
Vanguard Group Inc. lifted its holdings in shares of Bloom Energy Co. (NYSE:BE – Free Report) by 1.9% during the...
Mizuho Securities USA LLC Has $104.83 Million Position in Alphabet Inc. (NASDAQ:GOOGL)
Mizuho Securities USA LLC lifted its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 45.8% during the 4th quarter,...
Corebridge Financial Inc. Cuts Position in Insight Enterprises, Inc. (NASDAQ:NSIT)
Corebridge Financial Inc. trimmed its position in shares of Insight Enterprises, Inc. (NASDAQ:NSIT – Free Report) by 9.5% during the...
Millstone Evans Group LLC Purchases New Position in Alphabet Inc. (NASDAQ:GOOGL)
Millstone Evans Group LLC purchased a new stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) in the 4th...
Sciencast Management LP Sells 10,957 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Sciencast Management LP trimmed its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 65.4% in the fourth...